 Edward Hoffenberg
Concepts (339)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Celiac Disease | 29 | 2024 | 286 | 4.010 |
Why?
| | Crohn Disease | 11 | 2019 | 217 | 2.060 |
Why?
| | Inflammatory Bowel Diseases | 10 | 2022 | 326 | 1.880 |
Why?
| | Colitis, Ulcerative | 6 | 2019 | 120 | 1.540 |
Why?
| | Transglutaminases | 19 | 2024 | 153 | 1.510 |
Why?
| | Autoantibodies | 18 | 2024 | 1468 | 1.360 |
Why?
| | Marijuana Use | 2 | 2018 | 192 | 0.880 |
Why?
| | Medical Marijuana | 3 | 2019 | 111 | 0.720 |
Why?
| | Cannabinol | 1 | 2019 | 2 | 0.630 |
Why?
| | Anti-Inflammatory Agents | 4 | 2017 | 482 | 0.620 |
Why?
| | Mass Screening | 6 | 2024 | 1192 | 0.590 |
Why?
| | Dronabinol | 1 | 2019 | 203 | 0.520 |
Why?
| | Arterio-Arterial Fistula | 1 | 2016 | 4 | 0.510 |
Why?
| | Hematemesis | 1 | 2016 | 3 | 0.510 |
Why?
| | Aneurysm, Infected | 1 | 2016 | 4 | 0.500 |
Why?
| | Esophageal Fistula | 1 | 2016 | 19 | 0.500 |
Why?
| | Intestinal Polyps | 2 | 2013 | 17 | 0.480 |
Why?
| | Aortic Coarctation | 1 | 2016 | 83 | 0.460 |
Why?
| | Marijuana Smoking | 1 | 2018 | 247 | 0.460 |
Why?
| | Aortic Diseases | 1 | 2016 | 114 | 0.450 |
Why?
| | Health Services Misuse | 1 | 2014 | 35 | 0.450 |
Why?
| | Antibodies, Monoclonal | 4 | 2014 | 1368 | 0.420 |
Why?
| | Adolescent | 31 | 2024 | 20451 | 0.420 |
Why?
| | Gastrointestinal Agents | 3 | 2017 | 60 | 0.420 |
Why?
| | Capsule Endoscopy | 2 | 2013 | 18 | 0.420 |
Why?
| | Motivation | 1 | 2018 | 548 | 0.420 |
Why?
| | Intestinal Mucosa | 4 | 2015 | 593 | 0.420 |
Why?
| | Sertoli Cell Tumor | 1 | 2013 | 2 | 0.410 |
Why?
| | Peutz-Jeghers Syndrome | 1 | 2013 | 9 | 0.410 |
Why?
| | Intussusception | 1 | 2013 | 27 | 0.410 |
Why?
| | Child | 40 | 2024 | 20962 | 0.400 |
Why?
| | Short Bowel Syndrome | 3 | 2011 | 26 | 0.390 |
Why?
| | Immunosuppressive Agents | 1 | 2017 | 858 | 0.390 |
Why?
| | Immunoglobulin A | 8 | 2024 | 201 | 0.370 |
Why?
| | Cerebral Palsy | 1 | 2013 | 96 | 0.360 |
Why?
| | Humans | 73 | 2024 | 129847 | 0.360 |
Why?
| | Heart Transplantation | 1 | 2017 | 722 | 0.360 |
Why?
| | Jejunum | 1 | 2011 | 30 | 0.350 |
Why?
| | Gliadin | 2 | 2007 | 13 | 0.350 |
Why?
| | Gastrointestinal Tract | 1 | 2013 | 187 | 0.340 |
Why?
| | Child, Preschool | 25 | 2024 | 10522 | 0.340 |
Why?
| | Pyloric Stenosis | 1 | 2010 | 2 | 0.340 |
Why?
| | Autoimmunity | 4 | 2011 | 863 | 0.330 |
Why?
| | Intestine, Small | 6 | 2013 | 151 | 0.330 |
Why?
| | Clinical Laboratory Techniques | 1 | 2011 | 94 | 0.330 |
Why?
| | Gastrointestinal Hemorrhage | 2 | 2009 | 123 | 0.330 |
Why?
| | Jejunal Diseases | 1 | 2009 | 7 | 0.320 |
Why?
| | Diabetes Mellitus, Type 1 | 7 | 2017 | 3630 | 0.320 |
Why?
| | Ibuprofen | 1 | 2010 | 81 | 0.320 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2017 | 1284 | 0.290 |
Why?
| | Male | 40 | 2024 | 63759 | 0.290 |
Why?
| | Infusions, Intravenous | 1 | 2009 | 402 | 0.290 |
Why?
| | Infliximab | 4 | 2017 | 101 | 0.290 |
Why?
| | Colorado | 8 | 2024 | 4410 | 0.280 |
Why?
| | Delivery of Health Care | 1 | 2014 | 900 | 0.270 |
Why?
| | Wheat Hypersensitivity | 1 | 2007 | 4 | 0.270 |
Why?
| | Diet, Gluten-Free | 3 | 2024 | 42 | 0.270 |
Why?
| | Incidence | 5 | 2018 | 2646 | 0.270 |
Why?
| | Gastroenterology | 4 | 2023 | 177 | 0.260 |
Why?
| | Nutritional Support | 1 | 2006 | 32 | 0.250 |
Why?
| | Quality Improvement | 1 | 2014 | 1112 | 0.250 |
Why?
| | Female | 37 | 2024 | 68829 | 0.250 |
Why?
| | Enterocytes | 3 | 2003 | 16 | 0.240 |
Why?
| | Infusions, Parenteral | 1 | 2005 | 38 | 0.230 |
Why?
| | Infant | 22 | 2024 | 9018 | 0.230 |
Why?
| | HLA-DQ Antigens | 3 | 2017 | 179 | 0.230 |
Why?
| | HLA-DR Antigens | 3 | 2017 | 223 | 0.220 |
Why?
| | Glutens | 5 | 2005 | 57 | 0.220 |
Why?
| | Antibodies, Fungal | 2 | 2005 | 9 | 0.220 |
Why?
| | Emergency Service, Hospital | 1 | 2014 | 1920 | 0.210 |
Why?
| | Case-Control Studies | 6 | 2019 | 3384 | 0.210 |
Why?
| | Pregnancy Outcome | 1 | 2006 | 392 | 0.210 |
Why?
| | Time Factors | 7 | 2017 | 6550 | 0.210 |
Why?
| | Citrulline | 1 | 2003 | 43 | 0.200 |
Why?
| | Antioxidants | 2 | 1997 | 558 | 0.200 |
Why?
| | Genetic Predisposition to Disease | 5 | 2017 | 2271 | 0.200 |
Why?
| | Colonic Polyps | 2 | 2004 | 87 | 0.190 |
Why?
| | Severity of Illness Index | 3 | 2019 | 2739 | 0.190 |
Why?
| | Home Care Services | 1 | 2005 | 244 | 0.180 |
Why?
| | Child Development | 1 | 2006 | 459 | 0.180 |
Why?
| | Sensitivity and Specificity | 5 | 2009 | 1847 | 0.180 |
Why?
| | Follow-Up Studies | 6 | 2024 | 4896 | 0.180 |
Why?
| | Safety | 3 | 2017 | 335 | 0.180 |
Why?
| | Pregnancy Complications | 1 | 2006 | 494 | 0.180 |
Why?
| | Avena | 1 | 2000 | 4 | 0.170 |
Why?
| | Patient Satisfaction | 1 | 2005 | 639 | 0.170 |
Why?
| | Infant, Newborn | 10 | 2011 | 5772 | 0.170 |
Why?
| | Abdominal Pain | 2 | 1999 | 143 | 0.160 |
Why?
| | Ileal Diseases | 2 | 2014 | 13 | 0.160 |
Why?
| | Administration, Oral | 2 | 2019 | 787 | 0.160 |
Why?
| | Predictive Value of Tests | 4 | 2007 | 1951 | 0.160 |
Why?
| | Saccharomyces cerevisiae | 2 | 2005 | 530 | 0.160 |
Why?
| | Autoimmune Diseases | 3 | 2017 | 428 | 0.160 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2014 | 1205 | 0.150 |
Why?
| | Antibodies, Antineutrophil Cytoplasmic | 1 | 1999 | 35 | 0.150 |
Why?
| | Government Regulation | 1 | 2019 | 49 | 0.150 |
Why?
| | Surveys and Questionnaires | 4 | 2024 | 5437 | 0.150 |
Why?
| | Aminoglycosides | 1 | 2018 | 23 | 0.150 |
Why?
| | Diarrhea | 2 | 2018 | 181 | 0.150 |
Why?
| | Cannabinoids | 2 | 2017 | 154 | 0.150 |
Why?
| | Radioimmunoassay | 3 | 2005 | 175 | 0.140 |
Why?
| | Clostridium Infections | 1 | 2018 | 64 | 0.140 |
Why?
| | Urine | 1 | 2017 | 60 | 0.140 |
Why?
| | Risk Factors | 8 | 2017 | 9801 | 0.140 |
Why?
| | Biopsy, Needle | 2 | 2011 | 187 | 0.140 |
Why?
| | Prospective Studies | 6 | 2024 | 7158 | 0.140 |
Why?
| | Young Adult | 4 | 2019 | 12467 | 0.140 |
Why?
| | Feces | 3 | 2018 | 442 | 0.130 |
Why?
| | Endocannabinoids | 1 | 2017 | 53 | 0.130 |
Why?
| | Retrospective Studies | 9 | 2023 | 14553 | 0.130 |
Why?
| | Legislation, Drug | 1 | 2017 | 77 | 0.130 |
Why?
| | Numismatics | 1 | 2015 | 1 | 0.130 |
Why?
| | Failure to Thrive | 1 | 1996 | 29 | 0.130 |
Why?
| | Colonoscopy | 2 | 2017 | 237 | 0.130 |
Why?
| | Plasma | 1 | 2017 | 206 | 0.120 |
Why?
| | Quality Assurance, Health Care | 1 | 2018 | 318 | 0.120 |
Why?
| | Case Management | 1 | 1996 | 64 | 0.120 |
Why?
| | Duodenum | 4 | 2022 | 76 | 0.120 |
Why?
| | Rotavirus Infections | 3 | 2006 | 45 | 0.120 |
Why?
| | Serologic Tests | 3 | 2007 | 52 | 0.120 |
Why?
| | Alagille Syndrome | 1 | 1995 | 33 | 0.120 |
Why?
| | Quality of Health Care | 2 | 2018 | 610 | 0.120 |
Why?
| | Critical Pathways | 1 | 1996 | 86 | 0.120 |
Why?
| | Cross-Sectional Studies | 2 | 2018 | 5085 | 0.120 |
Why?
| | After-Hours Care | 1 | 2014 | 14 | 0.110 |
Why?
| | Biological Products | 1 | 2018 | 207 | 0.110 |
Why?
| | Pneumococcal Infections | 1 | 2016 | 112 | 0.110 |
Why?
| | Foreign Bodies | 1 | 2015 | 103 | 0.110 |
Why?
| | Tandem Mass Spectrometry | 1 | 2017 | 528 | 0.110 |
Why?
| | Colitis | 1 | 2017 | 245 | 0.110 |
Why?
| | Prevalence | 3 | 2013 | 2564 | 0.110 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 4 | 2009 | 836 | 0.110 |
Why?
| | Telemedicine | 1 | 2023 | 792 | 0.110 |
Why?
| | Streptococcus pneumoniae | 1 | 2016 | 161 | 0.110 |
Why?
| | Gastrointestinal Diseases | 1 | 1996 | 198 | 0.110 |
Why?
| | Quality of Life | 3 | 2024 | 2695 | 0.110 |
Why?
| | Self Report | 1 | 2018 | 800 | 0.110 |
Why?
| | Rotavirus | 4 | 2006 | 20 | 0.110 |
Why?
| | Biopsy | 3 | 2007 | 1089 | 0.110 |
Why?
| | Esophagus | 1 | 2015 | 251 | 0.110 |
Why?
| | Rectal Fistula | 1 | 2013 | 21 | 0.100 |
Why?
| | Treatment Outcome | 6 | 2018 | 10241 | 0.100 |
Why?
| | Age Factors | 3 | 2013 | 3161 | 0.100 |
Why?
| | Reactive Oxygen Species | 1 | 1996 | 592 | 0.100 |
Why?
| | Sertoli Cells | 1 | 2013 | 23 | 0.100 |
Why?
| | Laparoscopy | 1 | 1997 | 447 | 0.100 |
Why?
| | Health Plan Implementation | 1 | 2014 | 137 | 0.100 |
Why?
| | Drug Administration Schedule | 2 | 2018 | 766 | 0.100 |
Why?
| | Pigmentation | 1 | 2013 | 51 | 0.100 |
Why?
| | Stomach | 1 | 2013 | 109 | 0.100 |
Why?
| | Cholestasis | 1 | 1995 | 232 | 0.100 |
Why?
| | Colon | 2 | 2013 | 257 | 0.100 |
Why?
| | Receptors, Virus | 1 | 2011 | 82 | 0.090 |
Why?
| | Microvilli | 2 | 2001 | 79 | 0.090 |
Why?
| | Age of Onset | 1 | 2013 | 494 | 0.090 |
Why?
| | Cystic Fibrosis | 2 | 2015 | 1067 | 0.090 |
Why?
| | Health Care Costs | 1 | 2014 | 367 | 0.090 |
Why?
| | Risk Assessment | 2 | 2011 | 3269 | 0.090 |
Why?
| | Plant Proteins | 1 | 2011 | 89 | 0.080 |
Why?
| | GTP-Binding Proteins | 2 | 2024 | 158 | 0.080 |
Why?
| | Food Hypersensitivity | 2 | 2004 | 177 | 0.080 |
Why?
| | Age Distribution | 1 | 2011 | 372 | 0.080 |
Why?
| | Sex Distribution | 1 | 2011 | 359 | 0.080 |
Why?
| | Mutation, Missense | 1 | 2011 | 316 | 0.080 |
Why?
| | Statistics, Nonparametric | 2 | 2000 | 422 | 0.080 |
Why?
| | Hospitals, Pediatric | 1 | 2013 | 517 | 0.080 |
Why?
| | Cytomegalovirus Infections | 2 | 2001 | 190 | 0.080 |
Why?
| | Reference Values | 1 | 2011 | 796 | 0.080 |
Why?
| | Prednisolone | 1 | 2009 | 82 | 0.080 |
Why?
| | Diagnosis, Differential | 2 | 2007 | 1434 | 0.080 |
Why?
| | Practice Guidelines as Topic | 3 | 2023 | 1514 | 0.080 |
Why?
| | Antibodies | 1 | 2011 | 399 | 0.080 |
Why?
| | Immunohistochemistry | 2 | 2011 | 1690 | 0.080 |
Why?
| | Family | 1 | 2013 | 646 | 0.070 |
Why?
| | Anti-Bacterial Agents | 1 | 2018 | 1708 | 0.070 |
Why?
| | Antibodies, Viral | 3 | 2006 | 602 | 0.070 |
Why?
| | Laboratories | 1 | 2009 | 109 | 0.070 |
Why?
| | Prognosis | 3 | 2019 | 3773 | 0.070 |
Why?
| | Liver Transplantation | 1 | 1995 | 833 | 0.070 |
Why?
| | Cost-Benefit Analysis | 2 | 2014 | 569 | 0.070 |
Why?
| | Cafe-au-Lait Spots | 1 | 2007 | 4 | 0.070 |
Why?
| | Gastrointestinal Microbiome | 1 | 2015 | 641 | 0.070 |
Why?
| | Adult | 7 | 2019 | 35634 | 0.070 |
Why?
| | Endoscopy, Gastrointestinal | 1 | 2009 | 219 | 0.070 |
Why?
| | Sex Factors | 1 | 2013 | 1973 | 0.070 |
Why?
| | Self-Help Groups | 1 | 2007 | 34 | 0.070 |
Why?
| | Disease Progression | 1 | 2014 | 2628 | 0.070 |
Why?
| | Cisapride | 1 | 2006 | 5 | 0.060 |
Why?
| | Liver Cirrhosis | 2 | 2015 | 281 | 0.060 |
Why?
| | Apgar Score | 1 | 2006 | 16 | 0.060 |
Why?
| | Edible Grain | 1 | 2005 | 48 | 0.060 |
Why?
| | Infant, Low Birth Weight | 1 | 2006 | 134 | 0.060 |
Why?
| | Mycoses | 1 | 2005 | 73 | 0.060 |
Why?
| | Societies, Medical | 4 | 2018 | 759 | 0.060 |
Why?
| | Infant, Newborn, Diseases | 1 | 2006 | 111 | 0.060 |
Why?
| | Child Nutrition Disorders | 1 | 2004 | 20 | 0.060 |
Why?
| | Adenomatous Polyposis Coli | 2 | 2007 | 30 | 0.060 |
Why?
| | Cytoskeletal Proteins | 1 | 2004 | 147 | 0.050 |
Why?
| | Growth | 1 | 2004 | 59 | 0.050 |
Why?
| | Catheterization | 2 | 2001 | 176 | 0.050 |
Why?
| | Genetic Testing | 1 | 2007 | 422 | 0.050 |
Why?
| | Nutrition Assessment | 1 | 2004 | 86 | 0.050 |
Why?
| | Peptide Fragments | 1 | 2007 | 695 | 0.050 |
Why?
| | Atrophy | 1 | 2003 | 170 | 0.050 |
Why?
| | Research | 2 | 2004 | 420 | 0.050 |
Why?
| | Trans-Activators | 1 | 2004 | 392 | 0.050 |
Why?
| | T-Lymphocytes, Helper-Inducer | 2 | 1993 | 135 | 0.050 |
Why?
| | Paracentesis | 1 | 2001 | 12 | 0.050 |
Why?
| | Patient Compliance | 1 | 2006 | 568 | 0.050 |
Why?
| | Infant, Premature | 1 | 2006 | 541 | 0.050 |
Why?
| | Colonic Diseases | 1 | 2001 | 32 | 0.050 |
Why?
| | Ascites | 1 | 2001 | 44 | 0.050 |
Why?
| | Allergy and Immunology | 1 | 2002 | 42 | 0.050 |
Why?
| | North America | 2 | 2018 | 294 | 0.040 |
Why?
| | Evidence-Based Medicine | 1 | 2005 | 716 | 0.040 |
Why?
| | Lymphocyte Count | 1 | 2000 | 148 | 0.040 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2005 | 2016 | 0.040 |
Why?
| | Longitudinal Studies | 2 | 2006 | 2724 | 0.040 |
Why?
| | Cohort Studies | 2 | 2003 | 5444 | 0.040 |
Why?
| | Genes, p53 | 1 | 1999 | 70 | 0.040 |
Why?
| | Genes, ras | 1 | 1999 | 95 | 0.040 |
Why?
| | T-Lymphocytes | 1 | 2007 | 1937 | 0.040 |
Why?
| | Aneuploidy | 1 | 1999 | 92 | 0.040 |
Why?
| | Smoking | 1 | 2006 | 1502 | 0.040 |
Why?
| | Epithelial Cells | 1 | 2004 | 1063 | 0.040 |
Why?
| | Hospitals | 1 | 2023 | 649 | 0.040 |
Why?
| | Atmospheric Pressure | 1 | 2017 | 23 | 0.040 |
Why?
| | Limit of Detection | 1 | 2017 | 83 | 0.030 |
Why?
| | Anemia | 1 | 1999 | 162 | 0.030 |
Why?
| | Diet | 1 | 2005 | 1212 | 0.030 |
Why?
| | Glutathione Peroxidase | 1 | 1997 | 43 | 0.030 |
Why?
| | Placebo Effect | 1 | 1997 | 55 | 0.030 |
Why?
| | Receptors, Cannabinoid | 1 | 2017 | 15 | 0.030 |
Why?
| | Hospital Costs | 1 | 1997 | 115 | 0.030 |
Why?
| | Vitamin E | 1 | 1997 | 120 | 0.030 |
Why?
| | Biomarkers | 2 | 2009 | 3971 | 0.030 |
Why?
| | Bile Ducts, Extrahepatic | 1 | 1996 | 22 | 0.030 |
Why?
| | Ascorbic Acid | 1 | 1997 | 120 | 0.030 |
Why?
| | Homozygote | 2 | 2011 | 195 | 0.030 |
Why?
| | Nursing Audit | 1 | 1996 | 6 | 0.030 |
Why?
| | Free Radical Scavengers | 1 | 1996 | 83 | 0.030 |
Why?
| | Pediatric Nursing | 1 | 1996 | 39 | 0.030 |
Why?
| | Models, Nursing | 1 | 1996 | 35 | 0.030 |
Why?
| | Free Radicals | 1 | 1996 | 106 | 0.030 |
Why?
| | Lipid Peroxidation | 1 | 1996 | 152 | 0.030 |
Why?
| | Body Mass Index | 1 | 2004 | 2274 | 0.030 |
Why?
| | Disabled Persons | 1 | 1997 | 138 | 0.030 |
Why?
| | Portoenterostomy, Hepatic | 1 | 1995 | 45 | 0.030 |
Why?
| | Phagocytes | 1 | 1996 | 97 | 0.030 |
Why?
| | Glutathione | 1 | 1997 | 349 | 0.030 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2017 | 585 | 0.030 |
Why?
| | Capsule Endoscopes | 1 | 2015 | 7 | 0.030 |
Why?
| | Radioligand Assay | 2 | 2009 | 48 | 0.030 |
Why?
| | Leukocyte L1 Antigen Complex | 1 | 2015 | 30 | 0.030 |
Why?
| | Disease Management | 1 | 2019 | 592 | 0.030 |
Why?
| | Rats | 1 | 2003 | 5487 | 0.030 |
Why?
| | Permeability | 1 | 2015 | 158 | 0.030 |
Why?
| | Biliary Atresia | 1 | 1996 | 161 | 0.030 |
Why?
| | Pregnancy | 2 | 2006 | 6423 | 0.030 |
Why?
| | Controlled Clinical Trials as Topic | 1 | 2014 | 27 | 0.030 |
Why?
| | HLA Antigens | 2 | 2006 | 235 | 0.030 |
Why?
| | Child Health Services | 1 | 2016 | 184 | 0.030 |
Why?
| | Nurse Practitioners | 1 | 1996 | 133 | 0.030 |
Why?
| | Digestive System Surgical Procedures | 1 | 2014 | 98 | 0.030 |
Why?
| | Gene Expression | 1 | 1999 | 1465 | 0.030 |
Why?
| | Hospitalization | 1 | 2023 | 2079 | 0.030 |
Why?
| | Adaptation, Psychological | 1 | 1998 | 618 | 0.030 |
Why?
| | Animals | 4 | 2017 | 35409 | 0.020 |
Why?
| | Child Nutritional Physiological Phenomena | 2 | 2004 | 104 | 0.020 |
Why?
| | Survival Analysis | 1 | 1995 | 1271 | 0.020 |
Why?
| | Coxsackie and Adenovirus Receptor-Like Membrane Protein | 1 | 2011 | 7 | 0.020 |
Why?
| | Genotype | 1 | 2017 | 1829 | 0.020 |
Why?
| | Cricetulus | 1 | 2011 | 107 | 0.020 |
Why?
| | CHO Cells | 1 | 2011 | 155 | 0.020 |
Why?
| | Vacuoles | 2 | 2001 | 36 | 0.020 |
Why?
| | Cricetinae | 1 | 2011 | 280 | 0.020 |
Why?
| | Heterozygote | 1 | 2011 | 271 | 0.020 |
Why?
| | Morphogenesis | 1 | 2011 | 158 | 0.020 |
Why?
| | Survival Rate | 1 | 1995 | 1872 | 0.020 |
Why?
| | Feasibility Studies | 1 | 2014 | 870 | 0.020 |
Why?
| | Transfection | 1 | 2011 | 918 | 0.020 |
Why?
| | Thinness | 1 | 2009 | 89 | 0.020 |
Why?
| | Zebrafish Proteins | 1 | 2011 | 268 | 0.020 |
Why?
| | Methyltransferases | 1 | 2009 | 70 | 0.020 |
Why?
| | International Cooperation | 1 | 2009 | 177 | 0.020 |
Why?
| | Biomedical Research | 1 | 2014 | 640 | 0.020 |
Why?
| | Mutation | 1 | 1999 | 3706 | 0.020 |
Why?
| | Zebrafish | 1 | 2011 | 460 | 0.020 |
Why?
| | ROC Curve | 1 | 2009 | 504 | 0.020 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2011 | 820 | 0.020 |
Why?
| | Tuberculosis | 1 | 2009 | 273 | 0.020 |
Why?
| | Pediatrics | 1 | 2014 | 1074 | 0.020 |
Why?
| | Inflammation | 1 | 2017 | 2748 | 0.020 |
Why?
| | Iodide Peroxidase | 1 | 2005 | 28 | 0.010 |
Why?
| | Thyroglobulin | 1 | 2005 | 27 | 0.010 |
Why?
| | Seroepidemiologic Studies | 1 | 2005 | 157 | 0.010 |
Why?
| | Genes, APC | 1 | 2004 | 12 | 0.010 |
Why?
| | Antibody Specificity | 1 | 2005 | 185 | 0.010 |
Why?
| | Adenomatous Polyposis Coli Protein | 1 | 2004 | 20 | 0.010 |
Why?
| | Loss of Heterozygosity | 1 | 2004 | 45 | 0.010 |
Why?
| | Organ Specificity | 1 | 2005 | 295 | 0.010 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2011 | 2062 | 0.010 |
Why?
| | Phenotype | 1 | 2011 | 3062 | 0.010 |
Why?
| | Neutralization Tests | 2 | 1993 | 73 | 0.010 |
Why?
| | beta Catenin | 1 | 2004 | 224 | 0.010 |
Why?
| | Malabsorption Syndromes | 1 | 2002 | 17 | 0.010 |
Why?
| | Aging | 1 | 1992 | 1774 | 0.010 |
Why?
| | Transforming Growth Factor beta | 1 | 2004 | 462 | 0.010 |
Why?
| | Alleles | 1 | 2004 | 843 | 0.010 |
Why?
| | Plasma Volume | 1 | 2001 | 19 | 0.010 |
Why?
| | Gastroschisis | 1 | 2001 | 21 | 0.010 |
Why?
| | Punctures | 1 | 2001 | 40 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 2011 | 4077 | 0.010 |
Why?
| | Needles | 1 | 2001 | 57 | 0.010 |
Why?
| | Anastomosis, Surgical | 1 | 2001 | 150 | 0.010 |
Why?
| | United States | 1 | 2018 | 13913 | 0.010 |
Why?
| | Immunoglobulin G | 1 | 2005 | 851 | 0.010 |
Why?
| | Immunity, Cellular | 2 | 1993 | 265 | 0.010 |
Why?
| | Microscopy, Electron | 1 | 2001 | 425 | 0.010 |
Why?
| | Drainage | 1 | 2001 | 164 | 0.010 |
Why?
| | Mice | 1 | 2017 | 16983 | 0.010 |
Why?
| | Family Relations | 1 | 1998 | 87 | 0.010 |
Why?
| | Autoradiography | 1 | 1996 | 74 | 0.010 |
Why?
| | RNA-Directed DNA Polymerase | 1 | 1996 | 34 | 0.010 |
Why?
| | Single-Blind Method | 1 | 1996 | 271 | 0.010 |
Why?
| | Polymerase Chain Reaction | 1 | 1996 | 1033 | 0.010 |
Why?
| | RNA, Viral | 1 | 1996 | 620 | 0.010 |
Why?
| | Base Sequence | 1 | 1996 | 2142 | 0.010 |
Why?
| | Immunity, Maternally-Acquired | 1 | 1992 | 19 | 0.010 |
Why?
| | Middle Aged | 2 | 2007 | 31177 | 0.010 |
Why?
| | Antibody Formation | 1 | 1993 | 291 | 0.010 |
Why?
| | Molecular Sequence Data | 1 | 1996 | 2833 | 0.010 |
Why?
| | Acute Disease | 1 | 1993 | 980 | 0.010 |
Why?
| | Postoperative Complications | 1 | 2001 | 2481 | 0.010 |
Why?
| | Fetal Blood | 1 | 1992 | 318 | 0.010 |
Why?
| | Lymphocyte Activation | 1 | 1992 | 1110 | 0.000 |
Why?
| | Cell Line | 1 | 1993 | 2780 | 0.000 |
Why?
| | HIV Infections | 1 | 2002 | 2730 | 0.000 |
Why?
| | Aged | 1 | 1999 | 22107 | 0.000 |
Why?
|
|
Hoffenberg's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|